Skip to main content

Research Repository

Advanced Search

Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads

Hubin, Timothy J.; Walker, Ashlie N.; Davilla, Dustin J.; Carder Freeman, Ta Rynn N.; Epley, Brittany M.; Hasley, Travis R.; Amoyaw, Prince N.A.; Jain, Surendra; Archibald, Stephen J.; Prior, Timothy J.; Krause, Jeanette A.; Oliver, Allen G.; Tekwani, Babu L.; Khan, M. Omar F.

Authors

Timothy J. Hubin

Ashlie N. Walker

Dustin J. Davilla

Ta Rynn N. Carder Freeman

Brittany M. Epley

Travis R. Hasley

Prince N.A. Amoyaw

Surendra Jain

Profile image of Tim Prior

Dr Tim Prior T.Prior@hull.ac.uk
Senior Lecturer in Inorganic Chemistry

Jeanette A. Krause

Allen G. Oliver

Babu L. Tekwani

M. Omar F. Khan



Abstract

© 2019 A total of 44 bis-aryl-monocyclic polyamines, monoaryl-monocyclic polyamines and their transition metal complexes were prepared, chemically characterized, and screened in vitro against the Leishmania donovani promastigotes, axenic amastigotes and intracellular amastigotes in THP1 cells. The IC 50 and/or IC 90 values showed that 10 compounds were similarly active at about 2-fold less potent than known drug pentamidine against promastigotes. The most potent compound had an IC 50 of 2.82 µM (compared to 2.93 µM for pentamidine). Nine compounds were 1.1–13.6-fold more potent than pentamidine against axenic amastigotes, the most potent one being about 2-fold less potent than amphotericin B. Fourteen compounds were about 2–10 fold more potent than pentamidine, the most potent one is about 2-fold less potent than amphotericin B against intracellular amastigotes in THP1 cells. The 2 most promising compounds (FeL7Cl 2 and MnL7Cl 2 ), with strong activity against both promastigotes and amastigotes and no observable toxicity against the THP1 cells are the Fe 2+ - and Mn 2+ -complexes of a dibenzyl cyclen derivative. Only 2 of the 44 compounds showed observable cytotoxicity against THP1 cells. Tetraazamacrocyclic monocyclic polyamines represent a new class of antileishmanial lead structures that warrant follow up studies.

Citation

Hubin, T. J., Walker, A. N., Davilla, D. J., Carder Freeman, T. R. N., Epley, B. M., Hasley, T. R., Amoyaw, P. N., Jain, S., Archibald, S. J., Prior, T. J., Krause, J. A., Oliver, A. G., Tekwani, B. L., & Khan, M. O. F. (2019). Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads. Polyhedron, 163, 42-53. https://doi.org/10.1016/j.poly.2019.02.027

Journal Article Type Article
Acceptance Date Feb 14, 2019
Online Publication Date Feb 23, 2019
Publication Date May 1, 2019
Deposit Date Mar 29, 2019
Publicly Available Date Mar 29, 2019
Journal Polyhedron
Print ISSN 0277-5387
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 163
Pages 42-53
DOI https://doi.org/10.1016/j.poly.2019.02.027
Keywords Cyclen; Cyclam; Polyamine; Antileishmanial drug lead; Metal complexes
Public URL https://hull-repository.worktribe.com/output/1357749
Publisher URL https://www.sciencedirect.com/science/article/pii/S0277538719301287?via%3Dihub
Contract Date Mar 29, 2019

Files







You might also like



Downloadable Citations